TREATMENT OF A PEDIATRIC PATIENT WITH AN H3.3 K27M MUTANT DIPG WITH ONC201, A SELECTIVE DRD2 ANTAGONIST

被引：0
|
作者：
Suarez, Fernando [1 ]
Stafford, James M. [1 ]
Tarapore, Rohinton [2 ]
Oster, Wolfgang [2 ]
Allen, Joshua E. [2 ]
Chi, Andrew S. [1 ]
Gardner, Sharon [1 ]
机构：
[1] NYU Langone Hlth, New York, NY USA
[2] Oncoceutics, Philadelphia, PA USA
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
DIPG-54
引用
收藏
页码：60 / 60
页数：1
相关论文
共 50 条
  • [21] ONC201: THE FIRST SELECTIVE, NON-COMPETITIVE DRD2/3 ANTAGONIST FOR CLINICAL NEURO-ONCOLOGY
    Prabhu, Varun Vijay
    Madhukar, Neel
    Anantharaman, Lakshmi
    Sulli, Chidananda
    Davidson, Edgar
    Deacon, Sean
    Tarapore, Rohinton
    Rucker, Joseph
    Charter, Neil
    Doranz, Benjamin
    Oster, Wolfgang
    Stogniew, Martin
    Elemento, Olivier
    Free, R. Benjamin
    Sibley, David
    Allen, Joshua
    NEURO-ONCOLOGY, 2018, 20 : 71 - 71
  • [22] DIFFERENTIATED PHARMACOLOGY OF THE IMIPRIDONE ONC201, THE FIRST SELECTIVE DRD2/3 ANTAGONIST IN CLINICAL NEURO-ONCOLOGY
    Madhukar, Neel
    Prabhu, Varun Vijay
    Anantharaman, Lakshmi
    Sulli, Chidananda
    Davidson, Edgar
    Deacon, Sean
    Tarapore, Rohinton
    Rucker, Joseph
    Charter, Neil
    Doranz, Benjamin
    Oster, Wolfgang
    Elemento, Olivier
    Free, R. Benjamin
    Sibley, David
    Allen, Joshua E.
    NEURO-ONCOLOGY, 2017, 19 : 81 - 82
  • [23] Knock-down of H3.3 K27M mutant protein in DIPG cells delays, but does not abrogate, tumor growth in vivo
    Silveira, Andre B.
    Zhu, Xiaoyan
    Qu, Chunxu
    Baker, Suzanne
    CANCER RESEARCH, 2015, 75
  • [24] H3.3 K27M MUTATION IN NEURAL PROGENITOR CELLS DRIVES PEDIATRIC GLIOMA
    不详
    CANCER DISCOVERY, 2015, 5 (01) : 13 - 13
  • [25] PHASE 1 STUDY OF ONC201 IN PEDIATRIC PATIENTS WITH H3 K27M-MUTANT HIGH GRADE GLIOMA OR NEWLY DIAGNOSED DIPG
    Gardner, Sharon
    Suarez, Fernando
    Stafford, James M.
    Tarapore, Rohinton S.
    Merdinger, Krystal
    Oster, Wolfgang
    Allen, Joshua
    Chi, Andrew S.
    Fuller-Becker, Hope
    Yaffe, Anna
    Allen, Jeffrey C.
    NEURO-ONCOLOGY, 2018, 20 : 201 - 201
  • [26] H3 K27M MUTANT GLIOMAS ARE SELECTIVELY KILLED BY ONC201, A SMALL MOLECULE INHIBITOR OF DOPAMINE RECEPTOR D2
    Chi, Andrew S.
    Stafford, James M.
    Sen, Namita
    Possemato, Richard
    Placantonakis, Dimitris
    Hidalgo, Eveline Teresa
    Harter, David
    Wisoff, Jeffrey
    Golfinos, John
    Arrillaga-Romany, Isabel
    Batchelor, Tracy
    Wen, Patrick
    Wakimoto, Hiroaki
    Cahill, Daniel
    Allen, Joshua E.
    Oster, Wolfgang
    Snuderl, Matija
    NEURO-ONCOLOGY, 2017, 19 : 81 - 81
  • [27] Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression
    Lopez, Giselle Y.
    Bush, Nancy Ann Oberheim
    Phillips, Joanna J.
    Bouffard, John-Paul
    Moshel, Yaron A.
    Jaeckle, Kurt
    Kleinschmidt-DeMasters, B. K.
    Rosenblum, Marc K.
    Perry, Arie
    Solomon, David A.
    ACTA NEUROPATHOLOGICA, 2017, 134 (06) : 961 - 963
  • [28] Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression
    Giselle Y. Lopez
    Nancy Ann Oberheim Bush
    Joanna J. Phillips
    John-Paul Bouffard
    Yaron A. Moshel
    Kurt Jaeckle
    B. K. Kleinschmidt-DeMasters
    Marc K. Rosenblum
    Arie Perry
    David A. Solomon
    Acta Neuropathologica, 2017, 134 : 961 - 963
  • [29] CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA
    Kawakibi, Abed Rahman
    Gardner, Sharon
    Chi, Andrew
    Kurz, Sylvia
    Wen, Patrick
    Arrillaga-Romany, Isabel
    Batchelor, Tracy
    Butowski, Nicholas
    Sumrall, Ashley
    Shonka, Nicole
    Harrison, Rebecca
    DeGroot, John
    Mehta, Minesh
    Odia, Yazmin
    Hall, Matthew
    Daghistani, Doured
    Cloughesy, Timothy
    Ellingson, Benjamin
    Umemura, Yoshie
    Schwartz, Jonathan
    Yadav, Vivekanand
    Cartaxo, Rodrigo
    Miklja, Zachary
    Bruzek, Amy
    Siada, Ruby
    Mullan, Brendan
    Stallard, Stefanie
    Muruganand, Ashwath
    Wierzbicki, Kyle
    Paul, Alyssa
    Wolfe, Ian
    Kumar-Sinha, Chandan
    Marini, Bernard
    Leonard, Marcia
    Garton, Hugh
    Mody, Rajen
    Robertson, Patricia
    Merdinger, Krystal
    Tarapore, Rohinton
    Oster, Wolfgang
    Allen, Joshua
    Koschmann, Carl
    NEURO-ONCOLOGY, 2019, 21 : 186 - 186
  • [30] CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUTANT GLIOMA
    Kawakibi, Abed Rahman
    Tarapore, Rohinton S.
    Gardner, Sharon
    Chi, Andrew
    Kurz, Sylvia
    Wen, Patrick Y.
    Arrillaga-Romany, Isabel
    Batchelor, Tracy T.
    Butowski, Nicholas A.
    Sumrall, Ashley
    Shonka, Nicole
    Harrison, Rebecca
    DeGroot, John
    Mehta, Minesh
    Odia, Yazmin
    Hall, Matthew D.
    Daghistani, Doured
    Cloughesy, Timothy F.
    Ellingson, Benjamin M.
    Umemura, Yoshie
    Schwartz, Jonathan
    Yadav, Vivekanand
    Cartaxo, Rodrigo
    Siada, Ruby
    Miklja, Zachary
    Bruzek, Amy
    Cantor, Evan
    Wierzbicki, Kyle
    Paul, Alyssa
    Wolfe, Ian
    Leaoard, Marcia
    Garton, Hugh
    Mody, Rajen
    Robertson, Patricia L.
    Lu, Guangrong
    Merdinger, Krystal
    Venneti, Sriram
    Oster, Wolfgang
    Allen, Joshua E.
    Koschmann, Carl
    NEURO-ONCOLOGY, 2020, 22 : 347 - 347
12345